| 商品名称 | 适用类别 | 通用名称 | 活性成分 | 产品号 | 上市许可开发者/申请人/持有人 | 上市许可日期 | 许可状态 |
|---|---|---|---|---|---|---|---|
| Junod | Human | denosumab | denosumab | EMEA/H/C/006436 | Gedeon Richter Plc. | 2025/06/23 | Authorised |
| Yaxwer | Human | denosumab | denosumab | EMEA/H/C/006437 | Gedeon Richter Plc. | 2025/06/23 | Authorised |
| Tepezza | Human | teprotumumab | teprotumumab | EMEA/H/C/006396 | Amgen Europe B.V. | 2025/06/19 | Authorised |
| Sephience | Human | sepiapterin | sepiapterin | EMEA/H/C/006331 | PTC Therapeutics International Limited | 2025/06/19 | Authorised |
| Xoanacyl | Human | ferric citrate coordination complex | ferric citrate coordination complex | EMEA/H/C/006402 | Averoa | 2025/06/11 | Authorised |
| Duvyzat | Human | givinostat | givinostat hydrochloride monohydrate | EMEA/H/C/006079 | Italfarmaco S.p.A. | 2025/06/06 | Authorised |
| Qoyvolma | Human | ustekinumab | ustekinumab | EMEA/H/C/006649 | Celltrion Healthcare Hungary Kft. | 2025/06/02 | Authorised |
| Ryjunea | Human | atropine sulfate | atropine sulfate | EMEA/H/C/006324 | Santen Oy | 2025/06/02 | Authorised |
| Osvyrti | Human | denosumab | denosumab | EMEA/H/C/006399 | Accord Healthcare S.L.U. | 2025/05/26 | Authorised |
| Jubereq | Human | denosumab | denosumab | EMEA/H/C/006398 | Accord Healthcare S.L.U. | 2025/05/26 | Authorised |
| Deqsiga | Human | human normal immunoglobulin | human normal immunoglobulin | EMEA/H/C/006423 | Takeda Manufacturing Austria AG | 2025/05/02 | Authorised |
| Trabectedin Accord | Human | trabectedin | trabectedin | EMEA/H/C/006433 | Accord Healthcare S.L.U. | 2025/04/25 | Authorised |
| Lynozyfic | Human | linvoseltamab | linvoseltamab | EMEA/H/C/006370 | Regeneron Ireland Designated Activity Company (DAC) | 2025/04/23 | Authorised |
| Vyjuvek | Human | beremagene geperpavec | Beremagene geperpavec | EMEA/H/C/006330 | Krystal Biotech Netherlands B.V. | 2025/04/23 | Authorised |
| Leqembi | Human | lecanemab | Lecanemab | EMEA/H/C/005966 | Eisai GmbH | 2025/04/15 | Authorised |
| Datroway | Human | datopotamab deruxtecan | datopotamab deruxtecan | EMEA/H/C/006547 | Daiichi Sankyo Europe GmbH | 2025/04/04 | Authorised |
| Eltrombopag Accord | Human | eltrombopag | eltrombopag olamine | EMEA/H/C/006459 | Accord Healthcare S.L.U. | 2025/03/28 | Authorised |
| Tivdak | Human | tisotumab vedotin | tisotumab vedotin | EMEA/H/C/005363 | Genmab A/S | 2025/03/28 | Authorised |
| Dyrupeg | Human | pegfilgrastim | pegfilgrastim | EMEA/H/C/006407 | CuraTeQ Biologics s.r.o | 2025/03/28 | Authorised |
| Capvaxive | Human | pneumococcal polysaccharide conjugate vaccine (21-valent) | pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein | EMEA/H/C/006267 | Merck Sharp & Dohme B.V. | 2025/03/24 | Authorised |
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
药物在线相关数据库
